Figure 7.
Evolution of dual insulin-like growth factor 1 receptor/insulin receptor inhibitors derived from an imidazo[1,5-a]pyrazine scaffold and structure-based drug design efforts.
Evolution of dual insulin-like growth factor 1 receptor/insulin receptor inhibitors derived from an imidazo[1,5-a]pyrazine scaffold and structure-based drug design efforts.